+44 1223 790975
+44 1223 790975
Like us on:
organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Articles published in Journal of Alzheimers Disease & Parkinsonism have been cited by esteemed scholars and scientists all around the world. Journal of Alzheimers Disease & Parkinsonism has got h-index 25, which means every article in Journal of Alzheimers Disease & Parkinsonism has got 25 average citations.
Following are the list of articles that have cited the articles published in Journal of Alzheimers Disease & Parkinsonism.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Total published articles |
26 | 33 | 60 | 35 | 45 | 44 | 107 | 89 |
Conference proceedings |
0 | 33 | 0 | 0 | 82 | 213 | 118 | 158 |
Citations received as per Google Scholar, other indexing platforms and portals |
123 | 389 | 489 | 425 | 374 | 263 | 237 | 253 |
| Journal total citations count | 3123 |
| Journal impact factor | 2.04 |
| Journal 5 years impact factor | 3.14 |
| Journal cite score | 10.01 |
| Journal h-index | 25 |
| Journal h-index since 2019 | 22 |
 |
Molecular pathogenesis and interventional strategies for Alzheimer's disease: promises and pitfalls |
| | | | |
|
Significance of blood and cerebrospinal fluid biomarkers for Alzheimer's disease: sensitivity, specificity and potential for clinical use |
| | | | |
|
A young-onset frontal dementia with dramatic calcifications due to a novel CSF1R mutation |
| | | | |
|
Dietary arachidonic acid increases deleterious effects of amyloid-? oligomers on learning abilities and expression of AMPA receptors: putative role of the ACSL4-cPLA2 balance |
| | | | |
|
Regulation of microRNAs-mediated autophagic flux: a new regulatory avenue for neurodegenerative diseases with focus on prion diseases |
| | | | |
|
The role of retromer in Alzheimer's disease |
| | | | |
|
Evidence of CNS ?-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation |
| | | | |
|
Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease |
| | | | |
|
Over-expressed pathogenic miRNAs in Alzheimer's disease (AD) and prion disease (PrD) drive deficits in TREM2-mediated A?42 peptide clearance |
| | | | |
|
microRNA-based biomarkers and the diagnosis of Alzheimer's disease |
| | | | |
|
The glycosylated flavonoids vitexin, isovitexin, and quercetrin isolated from Serjania erecta Radlk (Sapindaceae) leaves protect PC12 cells against amyloid-?25-35 peptide-induced toxicity |
| | | | |
|
Alcohol and Alzheimer's Disease芒聙聰Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease? |
| | | | |
|
Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945 |
| | | | |
|
Developing therapeutic vaccines against Alzheimer's disease |
| | | | |
|
The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume |
| | | | |
|
Lymphatic drainage system of the brain: a novel target for intervention of neurological diseases |
| | | | |
|
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET |
| | | | |
|
Stem Cell Research Therapy for Neurodegenerative Disorders- In What Way to Make it Work |
| | | | |
|
Cancer-Related Reprogramming of Human by Tumor Suppressor Gene |
| | | | |
|
Depression: A Scientific Approach |
| | | | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, 黑料网 Journals
